WILLIAM K PLUNKETT JR to Topotecan
This is a "connection" page, showing publications WILLIAM K PLUNKETT JR has written about Topotecan.
Connection Strength
0.030
-
Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome. Cancer. 2006 Mar 01; 106(5):1099-109.
Score: 0.016
-
Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent. Cancer Chemother Pharmacol. 1994; 34(3):249-56.
Score: 0.007
-
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia. Blood. 1993 Mar 01; 81(5):1146-51.
Score: 0.007